Proteinuria following conversion from azathioprine to sirolimus in renal transplant recipients. (Q53604923)

16 May 2018

title

Proteinuria following conversion from azathioprine to sirolimus in renal transplant recipients. (English)

1 reference

16 May 2018

1 reference

1 reference

van den Akker JM

1

1 reference

16 May 2018

Wetzels JF

series ordinal

2

1 reference

16 May 2018

Hoitsma AJ

series ordinal

3

1 reference

16 May 2018

language of work or name

English

0 references

publication date

16 August 2006

1 reference

16 May 2018

published in

Kidney International

1 reference

16 May 2018

volume

70

1 reference

16 May 2018

issue

7

1 reference

16 May 2018

page(s)

1355-1357

1 reference

16 May 2018

Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001792

7 January 2021

Sirolimus therapy without calcineurin inhibitors: Necker Hospital 8-year experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001792

7 January 2021

Proteinuria following a switch from calcineurin inhibitors to sirolimus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001792

7 January 2021

Evolution of proteinuria after conversion from calcineurin inhibitors (CNI) to sirolimus (SRL) in renal transplant patients: a multicenter study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001792

7 January 2021

Is sirolimus responsible for proteinuria?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001792

7 January 2021

Rapamycin-associated post-transplantation glomerulonephritis and its remission after reintroduction of calcineurin-inhibitor therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001792

7 January 2021

Investigation of pediatric renal transplant recipients with heavy proteinuria after sirolimus rescue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001792

7 January 2021

Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001792

7 January 2021

Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001792

7 January 2021

Proteinuria after renal transplantation affects not only graft survival but also patient survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001792

7 January 2021

Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001792

7 January 2021

Sirolimus-associated heavy proteinuria in a renal transplant recipient: evidence for a tubular mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001792

7 January 2021

Rapamycin worsens renal function and intratubular cast formation in protein overload nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001792

7 January 2021

Conversion from cyclosporine to sirolimus in stable renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001792

7 January 2021

National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001792

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5001792

1 reference

16 May 2018

1 reference

16 May 2018